# s_type = frag
# newdoc id = AMALGUM_academic_cyclic
# sent_id = AMALGUM_academic_cyclic-1
# text = 1. Introduction
1	1.	1.	X	LS	_	2	dep	2:dep	Discourse=preparation:1->4
2	Introduction	introduction	NOUN	NN	Number=Sing	0	root	0:root	Entity=(abstract-1)

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-2
# text = Proteases are associated with many signaling biological pathways , and it is has been proven that the number of diseases like cancer , HIV , infectious diseases , and diabetes are treated by inhibiting proteases .
1	Proteases	protease	NOUN	NNS	Number=Plur	3	nsubj:pass	3:nsubj:pass	Discourse=preparation:2->4|Entity=(abstract-2)
2	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	3	aux:pass	3:aux:pass	_
3	associated	associate	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
4	with	with	ADP	IN	_	8	case	8:case	_
5	many	many	ADJ	JJ	Degree=Pos	8	amod	8:amod	Entity=(abstract-3
6	signaling	signal	VERB	VBG	VerbForm=Ger	8	amod	8:amod	_
7	biological	biological	ADJ	JJ	Degree=Pos	8	amod	8:amod	_
8	pathways	pathway	NOUN	NNS	Number=Plur	3	obl	3:obl:with	Entity=abstract-3)
9	,	,	PUNCT	,	_	15	punct	15:punct	_
10	and	and	CCONJ	CC	_	15	cc	15:cc	Discourse=attribution:3->4
11	it	it	PRON	PRP	Case=Acc|Gender=Neut|Number=Sing|Person=3|PronType=Prs	15	expl	15:expl	Entity=(abstract-1)
12	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	15	aux:pass	15:aux:pass	_
13	has	have	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	15	aux	15:aux	_
14	been	be	AUX	VBN	Tense=Past|VerbForm=Part	15	aux:pass	15:aux:pass	_
15	proven	prove	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	3	conj	3:conj:and	_
16	that	that	SCONJ	IN	_	32	mark	32:mark	Discourse=ROOT:4
17	the	the	DET	DT	Definite=Def|PronType=Art	18	det	18:det	Entity=(abstract-4
18	number	number	NOUN	NN	Number=Sing	32	nsubj:pass	32:nsubj:pass	_
19	of	of	ADP	IN	_	20	case	20:case	_
20	diseases	disease	NOUN	NNS	Number=Plur	18	nmod	18:nmod:of	Entity=(abstract-5
21	like	like	ADP	IN	_	22	case	22:case	_
22	cancer	cancer	NOUN	NN	Number=Sing	20	nmod	20:nmod:like	Entity=(abstract-6)
23	,	,	PUNCT	,	_	24	punct	24:punct	_
24	HIV	HIV	NOUN	NN	Abbr=Yes|Number=Sing	22	conj	20:nmod:like|22:conj:and	Entity=(abstract-7)
25	,	,	PUNCT	,	_	27	punct	27:punct	_
26	infectious	infectious	ADJ	JJ	Degree=Pos	27	amod	27:amod	Entity=(abstract-5
27	diseases	disease	NOUN	NNS	Number=Plur	22	conj	20:nmod:like|22:conj:and	Entity=abstract-5)
28	,	,	PUNCT	,	_	30	punct	30:punct	_
29	and	and	CCONJ	CC	_	30	cc	30:cc	_
30	diabetes	diabet	NOUN	NN	Number=Sing	22	conj	20:nmod:like|22:conj:and	Entity=abstract-4)abstract-5)(abstract-8)
31	are	be	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	32	aux:pass	32:aux:pass	_
32	treated	treat	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	15	csubj:pass	15:csubj:pass	_
33	by	by	SCONJ	IN	_	34	mark	34:mark	Discourse=means:5->4
34	inhibiting	inhibit	VERB	VBG	VerbForm=Ger	32	advcl	32:advcl:by	_
35	proteases	protease	NOUN	NNS	Number=Plur	34	obj	34:obj	Entity=(abstract-2)
36	.	.	PUNCT	.	_	3	punct	3:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-3
# text = Pharmaceutical companies develop commercial drugs to inhibit aspartyl proteases , serine proteases , and cysteine proteases .
1	Pharmaceutical	Pharmaceutical	ADJ	JJ	Degree=Pos	2	amod	2:amod	Discourse=joint:6->4|Entity=(organization-9
2	companies	company	NOUN	NNS	Number=Plur	3	nsubj	3:nsubj	Entity=organization-9)
3	develop	develop	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
4	commercial	commercial	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(substance-10
5	drugs	drug	NOUN	NNS	Number=Plur	3	obj	3:obj	_
6	to	to	PART	TO	_	7	mark	7:mark	Discourse=purpose:7->6
7	inhibit	inhibit	VERB	VB	VerbForm=Inf	5	acl	5:acl:to	_
8	aspartyl	aspartyl	NOUN	NN	Number=Sing	9	compound	9:compound	Entity=(abstract-2(abstract-2(abstract-11)
9	proteases	protease	NOUN	NNS	Number=Plur	7	obj	7:obj	Entity=abstract-2)
10	,	,	PUNCT	,	_	12	punct	12:punct	_
11	serine	serine	NOUN	NN	Number=Sing	12	compound	12:compound	Entity=(abstract-2(animal-12)
12	proteases	protease	NOUN	NNS	Number=Plur	9	conj	7:obj|9:conj:and	Entity=abstract-2)
13	,	,	PUNCT	,	_	16	punct	16:punct	_
14	and	and	CCONJ	CC	_	16	cc	16:cc	_
15	cysteine	cysteine	NOUN	NN	Number=Sing	16	compound	16:compound	Entity=(abstract-2(abstract-13)
16	proteases	protease	NOUN	NNS	Number=Plur	9	conj	7:obj|9:conj:and	Entity=substance-10)abstract-2)abstract-2)
17	.	.	PUNCT	.	_	3	punct	3:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-4
# text = Among several protease inhibitors , serine protease inhibitors received significant interest in various applications focused mainly in therapeutics .
1	Among	among	ADP	IN	_	4	case	4:case	Discourse=joint:8->4
2	several	several	ADJ	JJ	Degree=Pos	4	amod	4:amod	Entity=(abstract-14
3	protease	protease	NOUN	NN	Number=Sing	4	compound	4:compound	Entity=(abstract-15)
4	inhibitors	inhibitor	NOUN	NNS	Number=Plur	9	obl	9:obl:among	Entity=abstract-14)
5	,	,	PUNCT	,	_	4	punct	4:punct	_
6	serine	serine	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(abstract-16(animal-12)
7	protease	protease	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(abstract-15)
8	inhibitors	inhibitor	NOUN	NNS	Number=Plur	9	nsubj	9:nsubj	Entity=abstract-16)
9	received	receive	VERB	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
10	significant	significant	ADJ	JJ	Degree=Pos	11	amod	11:amod	Entity=(abstract-17
11	interest	interest	NOUN	NN	Number=Sing	9	obj	9:obj	Entity=abstract-17)
12	in	in	ADP	IN	_	14	case	14:case	_
13	various	various	ADJ	JJ	Degree=Pos	14	amod	14:amod	Entity=(abstract-18
14	applications	application	NOUN	NNS	Number=Plur	9	obl	9:obl:in	_
15	focused	focus	VERB	VBN	Tense=Past|VerbForm=Part	14	acl	14:acl	Discourse=elaboration:9->8
16	mainly	mainly	ADV	RB	Degree=Pos	15	advmod	15:advmod	_
17	in	in	ADP	IN	_	18	case	18:case	_
18	therapeutics	therapeutics	NOUN	NNS	Number=Plur	15	obl	15:obl:in	Entity=abstract-18)(abstract-19)
19	.	.	PUNCT	.	_	9	punct	9:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-5
# text = Serine protease inhibitors shown in Table 1 , are used in treating diseases like immune-related disorders , inflammatory , respiratory , AIDS , neurodegenerative , and metabolic disorders .
1	Serine	serine	NOUN	NN	Number=Sing	2	compound	2:compound	Discourse=joint:10->4|Entity=(abstract-16(abstract-15(animal-12)
2	protease	protease	NOUN	NN	Number=Sing	3	compound	3:compound	Entity=abstract-15)
3	inhibitors	inhibitor	NOUN	NNS	Number=Plur	10	nsubj:pass	10:nsubj:pass	_
4	shown	show	VERB	VBN	Tense=Past|VerbForm=Part	3	acl	3:acl	Discourse=elaboration:11->10
5	in	in	ADP	IN	_	6	case	6:case	_
6	Table	Table	PROPN	NNP	Number=Sing	4	obl	4:obl:in	Entity=(abstract-20
7	1	1	NUM	CD	NumForm=Digit|NumType=Card	6	dep	6:dep	Entity=abstract-16)abstract-20)
8	,	,	PUNCT	,	_	3	punct	3:punct	_
9	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	10	aux:pass	10:aux:pass	Discourse=attribution:12->13
10	used	use	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
11	in	in	SCONJ	IN	_	12	mark	12:mark	Discourse=same_unit:13->10
12	treating	treat	VERB	VBG	VerbForm=Ger	10	advcl	10:advcl:in	_
13	diseases	disease	NOUN	NNS	Number=Plur	12	obj	12:obj	Entity=(abstract-5
14	like	like	ADP	IN	_	16	case	16:case	_
15	immune-related	immune-related	ADJ	JJ	Degree=Pos	16	amod	16:amod	Entity=(abstract-21
16	disorders	disorder	NOUN	NNS	Number=Plur	13	nmod	13:nmod:like	Entity=abstract-21)
17	,	,	PUNCT	,	_	18	punct	18:punct	_
18	inflammatory	inflammatory	ADJ	JJ	Degree=Pos	16	conj	13:nmod:like|16:conj:and	_
19	,	,	PUNCT	,	_	20	punct	20:punct	_
20	respiratory	respiratory	ADJ	JJ	Degree=Pos	16	conj	13:nmod:like|16:conj:and	_
21	,	,	PUNCT	,	_	22	punct	22:punct	_
22	AIDS	AIDS	PROPN	NNP	Abbr=Yes|Number=Sing	16	conj	13:nmod:like|16:conj:and	Entity=(abstract-22)
23	,	,	PUNCT	,	_	24	punct	24:punct	_
24	neurodegenerative	neurodegenerative	ADJ	JJ	Degree=Pos	16	conj	13:nmod:like|16:conj:and	_
25	,	,	PUNCT	,	_	28	punct	28:punct	_
26	and	and	CCONJ	CC	_	28	cc	28:cc	_
27	metabolic	metabolic	ADJ	JJ	Degree=Pos	28	amod	28:amod	Entity=(abstract-23
28	disorders	disorder	NOUN	NNS	Number=Plur	16	conj	13:nmod:like|16:conj:and	Entity=abstract-5)abstract-23)
29	.	.	PUNCT	.	_	10	punct	10:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-6
# text = Features like therapeutic potential , good binding affinity , low toxicity , and quickly cleavable by proteolytic enzymes , make cyclic peptides potential future therapeutics .
1	Features	feature	NOUN	NNS	Number=Plur	20	nsubj	20:nsubj|25:nsubj:xsubj	Discourse=joint:14->4|Entity=(abstract-24
2	like	like	ADP	IN	_	4	case	4:case	_
3	therapeutic	therapeutic	ADJ	JJ	Degree=Pos	4	amod	4:amod	Entity=(abstract-25
4	potential	potential	NOUN	NN	Number=Sing	1	nmod	1:nmod:like	Entity=abstract-25)
5	,	,	PUNCT	,	_	8	punct	8:punct	_
6	good	good	ADJ	JJ	Degree=Pos	8	amod	8:amod	Entity=(abstract-26
7	binding	binding	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(object-27)
8	affinity	affinity	NOUN	NN	Number=Sing	4	conj	1:nmod:like|4:conj	Entity=abstract-26)
9	,	,	PUNCT	,	_	11	punct	11:punct	_
10	low	low	ADJ	JJ	Degree=Pos	11	amod	11:amod	Entity=(abstract-28
11	toxicity	toxicity	NOUN	NN	Number=Sing	4	conj	1:nmod:like|4:conj	Entity=abstract-24)abstract-28)
12	,	,	PUNCT	,	_	15	punct	15:punct	_
13	and	and	CCONJ	CC	_	15	cc	15:cc	_
14	quickly	quickly	ADV	RB	Degree=Pos	15	advmod	15:advmod	_
15	cleavable	cleavable	ADJ	JJ	Degree=Pos	1	conj	1:conj:and|20:nsubj:xsubj|25:nsubj:xsubj	_
16	by	by	ADP	IN	_	18	case	18:case	_
17	proteolytic	proteolytic	ADJ	JJ	Degree=Pos	18	amod	18:amod	Entity=(substance-29
18	enzymes	enzyme	NOUN	NNS	Number=Plur	15	obl	15:obl:by	Entity=substance-29)
19	,	,	PUNCT	,	_	1	punct	1:punct	_
20	make	make	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	Discourse=joint:15->4
21	cyclic	cyclic	ADJ	JJ	Degree=Pos	22	amod	22:amod	Entity=(substance-30
22	peptides	peptide	NOUN	NNS	Number=Plur	20	iobj	20:iobj	Entity=substance-30)
23	potential	potential	ADJ	JJ	Degree=Pos	25	amod	25:amod	_
24	future	future	ADJ	JJ	Degree=Pos	25	amod	25:amod	_
25	therapeutics	therapeutics	NOUN	NNS	Number=Plur	20	xcomp	20:xcomp	_
26	.	.	PUNCT	.	_	20	punct	20:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-7
# text = Most of the cyclic peptides approved by the FDA ( shown in Table 2 ) are used in bacterial and fungal infections , oncology drugs , gastrointestinal disorders , and anemia .
1	Most	most	ADJ	JJS	Degree=Sup	17	nsubj:pass	17:nsubj:pass	Discourse=joint:16->4|Entity=(substance-30
2	of	of	ADP	IN	_	5	case	5:case	_
3	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	_
4	cyclic	cyclic	ADJ	JJ	Degree=Pos	5	amod	5:amod	_
5	peptides	peptide	NOUN	NNS	Number=Plur	1	obl	1:obl:of	_
6	approved	approve	VERB	VBN	Tense=Past|VerbForm=Part	5	acl	5:acl	Discourse=elaboration:17->16
7	by	by	ADP	IN	_	9	case	9:case	_
8	the	the	DET	DT	Definite=Def|PronType=Art	9	det	9:det	Entity=(organization-31
9	FDA	FDA	PROPN	NNP	Number=Sing	6	obl	6:obl:by	Entity=substance-30)organization-31)
10	(	(	PUNCT	-LRB-	_	11	punct	11:punct	Discourse=elaboration:18->16
11	shown	show	VERB	VBN	Tense=Past|VerbForm=Part	5	dep	5:dep	_
12	in	in	ADP	IN	_	13	case	13:case	_
13	Table	Table	PROPN	NNP	Number=Sing	11	obl	11:obl:in	Entity=(abstract-32
14	2	2	NUM	CD	NumForm=Digit|NumType=Card	13	dep	13:dep	Entity=abstract-32)
15	)	)	PUNCT	-RRB-	_	11	punct	11:punct	_
16	are	be	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	17	aux:pass	17:aux:pass	Discourse=same_unit:19->16
17	used	use	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
18	in	in	ADP	IN	_	22	case	22:case	_
19	bacterial	bacterial	ADJ	JJ	Degree=Pos	22	amod	22:amod	Entity=(abstract-33
20	and	and	CCONJ	CC	_	21	cc	21:cc	_
21	fungal	fungal	ADJ	JJ	Degree=Pos	19	conj	19:conj:and|22:amod	_
22	infections	infection	NOUN	NNS	Number=Plur	17	obl	17:obl:in	Entity=abstract-33)
23	,	,	PUNCT	,	_	25	punct	25:punct	_
24	oncology	oncology	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(substance-10(abstract-34)
25	drugs	drug	NOUN	NNS	Number=Plur	22	conj	17:obl:in|22:conj:and	Entity=substance-10)
26	,	,	PUNCT	,	_	28	punct	28:punct	_
27	gastrointestinal	gastrointestinal	ADJ	JJ	Degree=Pos	28	amod	28:amod	Entity=(abstract-23
28	disorders	disorder	NOUN	NNS	Number=Plur	22	conj	17:obl:in|22:conj:and	Entity=abstract-23)
29	,	,	PUNCT	,	_	31	punct	31:punct	_
30	and	and	CCONJ	CC	_	31	cc	31:cc	_
31	anemia	anemia	NOUN	NN	Number=Sing	22	conj	17:obl:in|22:conj:and	Entity=(abstract-35)
32	.	.	PUNCT	.	_	17	punct	17:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-8
# text = Recently , cyclic peptides were proven to inhibit HIV-1 protease ( aspartyl proteases ) and elastase , shedding light onto the use of cyclic peptides as protease inhibitors .
1	Recently	recently	ADV	RB	Degree=Pos	6	advmod	6:advmod	Discourse=elaboration:20->16
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	cyclic	cyclic	ADJ	JJ	Degree=Pos	4	amod	4:amod	Entity=(substance-30
4	peptides	peptide	NOUN	NNS	Number=Plur	6	nsubj:pass	6:nsubj:pass|8:nsubj:xsubj	Entity=substance-30)
5	were	be	AUX	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	6	aux:pass	6:aux:pass	_
6	proven	prove	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
7	to	to	PART	TO	_	8	mark	8:mark	_
8	inhibit	inhibit	VERB	VB	VerbForm=Inf	6	xcomp	6:xcomp	_
9	HIV-1	HIV-1	PROPN	NNP	Number=Sing	10	compound	10:compound	Entity=(abstract-15(abstract-36)
10	protease	protease	NOUN	NN	Number=Sing	8	obj	8:obj	Entity=abstract-15)
11	(	(	PUNCT	-LRB-	_	13	punct	13:punct	Discourse=elaboration:21->20
12	aspartyl	aspartyl	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(abstract-15(abstract-11)
13	proteases	protease	NOUN	NNS	Number=Plur	10	appos	10:appos	Entity=abstract-15)
14	)	)	PUNCT	-RRB-	_	13	punct	13:punct	_
15	and	and	CCONJ	CC	_	16	cc	16:cc	Discourse=same_unit:22->20
16	elastase	elastase	NOUN	NN	Number=Sing	10	conj	8:obj|10:conj:and	Entity=(abstract-37)
17	,	,	PUNCT	,	_	18	punct	18:punct	_
18	shedding	shed	VERB	VBG	VerbForm=Ger	8	advcl	8:advcl	Discourse=elaboration:23->22
19	light	light	NOUN	NN	Number=Sing	18	obj	18:obj	Entity=(abstract-38)
20	onto	onto	ADP	IN	_	22	case	22:case	_
21	the	the	DET	DT	Definite=Def|PronType=Art	22	det	22:det	Entity=(abstract-39
22	use	use	NOUN	NN	Number=Sing	18	obl	18:obl:onto	_
23	of	of	ADP	IN	_	25	case	25:case	_
24	cyclic	cyclic	ADJ	JJ	Degree=Pos	25	amod	25:amod	Entity=(substance-30
25	peptides	peptide	NOUN	NNS	Number=Plur	22	nmod	22:nmod:of	_
26	as	as	ADP	IN	_	28	case	28:case	_
27	protease	protease	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=(abstract-16(abstract-15)
28	inhibitors	inhibitor	NOUN	NNS	Number=Plur	25	nmod	25:nmod:as	Entity=abstract-39)substance-30)abstract-16)
29	.	.	PUNCT	.	_	6	punct	6:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-9
# text = Phage display technology , Incretin-based cyclic peptide , cyclic peptides from mRNA display , and split-pool synthesis are some of the tools used to develop cyclic peptide compounds .
1	Phage	phage	NOUN	NN	Number=Sing	2	compound	2:compound	Discourse=joint:24->4|Entity=(abstract-40(object-41(place-42)
2	display	display	NOUN	NN	Number=Sing	3	compound	3:compound	Entity=object-41)
3	technology	technology	NOUN	NN	Number=Sing	19	nsubj	19:nsubj	Entity=abstract-40)
4	,	,	PUNCT	,	_	7	punct	7:punct	_
5	Incretin-based	incretin-based	NOUN	NN	Number=Sing	7	compound	7:compound	Entity=(substance-43(abstract-44)
6	cyclic	cyclic	ADJ	JJ	Degree=Pos	7	amod	7:amod	_
7	peptide	peptide	NOUN	NN	Number=Sing	3	conj	3:conj:and|19:nsubj	Entity=substance-43)
8	,	,	PUNCT	,	_	10	punct	10:punct	_
9	cyclic	cyclic	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(substance-30
10	peptides	peptide	NOUN	NNS	Number=Plur	3	conj	3:conj:and|19:nsubj	_
11	from	from	ADP	IN	_	13	case	13:case	_
12	mRNA	mRNA	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(object-41(event-45)
13	display	display	NOUN	NN	Number=Sing	10	nmod	10:nmod:from	Entity=substance-30)object-41)
14	,	,	PUNCT	,	_	17	punct	17:punct	_
15	and	and	CCONJ	CC	_	17	cc	17:cc	_
16	split-pool	split-pool	NOUN	NN	Number=Sing	17	compound	17:compound	Entity=(abstract-46
17	synthesis	synthesis	NOUN	NN	Number=Sing	3	conj	3:conj:and|19:nsubj	Entity=abstract-46)
18	are	be	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	19	cop	19:cop	_
19	some	some	PRON	DT	_	0	root	0:root	_
20	of	of	ADP	IN	_	22	case	22:case	_
21	the	the	DET	DT	Definite=Def|PronType=Art	22	det	22:det	Entity=(object-47
22	tools	tool	NOUN	NNS	Number=Plur	19	nmod	19:nmod:of	_
23	used	use	VERB	VBN	Tense=Past|VerbForm=Part	22	acl	22:acl	Discourse=elaboration:25->24
24	to	to	PART	TO	_	25	mark	25:mark	Discourse=purpose:26->25
25	develop	develop	VERB	VB	VerbForm=Inf	23	xcomp	23:xcomp	_
26	cyclic	cyclic	ADJ	JJ	Degree=Pos	27	amod	27:amod	Entity=(substance-48(substance-43
27	peptide	peptide	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=substance-43)
28	compounds	compound	NOUN	NNS	Number=Plur	25	obj	25:obj	Entity=object-47)substance-48)
29	.	.	PUNCT	.	_	19	punct	19:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-10
# text = Recently computer-aided drug design technologies like molecular docking simulations are applied to identify , design rationally ( called as de novo developed ) , and develop cyclic peptide ligand as leads to therapeutic drug targets of interest .
1	Recently	recently	ADV	RB	Degree=Pos	11	advmod	11:advmod	Discourse=joint:27->4
2	computer-aided	computer-aided	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(abstract-49
3	drug	drug	NOUN	NN	Number=Sing	4	compound	4:compound	Entity=(abstract-50(substance-51)
4	design	design	NOUN	NN	Number=Sing	5	compound	5:compound	Entity=abstract-50)
5	technologies	technology	NOUN	NNS	Number=Plur	11	nsubj:pass	11:nsubj:pass|13:nsubj:xsubj|15:nsubj:xsubj|26:nsubj:xsubj	_
6	like	like	ADP	IN	_	9	case	9:case	_
7	molecular	molecular	ADJ	JJ	Degree=Pos	8	amod	8:amod	Entity=(abstract-52(event-53
8	docking	docking	NOUN	NN	Number=Sing	9	compound	9:compound	Entity=event-53)
9	simulations	simulation	NOUN	NNS	Number=Plur	5	nmod	5:nmod:like	Entity=abstract-49)abstract-52)
10	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	11	aux:pass	11:aux:pass	_
11	applied	apply	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
12	to	to	PART	TO	_	13	mark	13:mark	Discourse=purpose:28->27
13	identify	identify	VERB	VB	VerbForm=Inf	11	xcomp	11:xcomp	_
14	,	,	PUNCT	,	_	15	punct	15:punct	_
15	design	design	VERB	VB	Mood=Imp|Person=2|VerbForm=Fin	13	conj	11:xcomp|13:conj:and	Discourse=sequence:29->27
16	rationally	rationally	ADV	RB	Degree=Pos	15	advmod	15:advmod	_
17	(	(	PUNCT	-LRB-	_	18	punct	18:punct	Discourse=elaboration:30->29
18	called	call	VERB	VBN	Tense=Past|VerbForm=Part	13	advcl	13:advcl	_
19	as	as	ADP	IN	_	22	case	22:case	_
20	de	de	NUM	NNP	Number=Sing	21	nummod	21:nummod	Entity=(abstract-54
21	novo	Novo	PROPN	NNP	Number=Sing	22	obl:tmod	22:obl:tmod	Entity=abstract-54)
22	developed	develop	VERB	VBN	Tense=Past|VerbForm=Part	18	advcl	18:advcl	_
23	)	)	PUNCT	-RRB-	_	18	punct	18:punct	_
24	,	,	PUNCT	,	_	26	punct	26:punct	_
25	and	and	CCONJ	CC	_	26	cc	26:cc	Discourse=sequence:31->27
26	develop	develop	VERB	VB	Mood=Imp|Person=2|VerbForm=Fin	13	conj	11:xcomp|13:conj:and	_
27	cyclic	cyclic	ADJ	JJ	Degree=Pos	29	amod	29:amod	Entity=(substance-55
28	peptide	peptide	NOUN	NN	Number=Sing	29	compound	29:compound	Entity=(substance-43)
29	ligand	ligand	NOUN	NN	Number=Sing	26	obj	26:obj	Entity=substance-55)
30	as	as	ADP	IN	_	31	case	31:case	_
31	leads	lead	NOUN	NNS	Number=Plur	26	obl	26:obl:as	Entity=(abstract-56
32	to	to	ADP	IN	_	35	case	35:case	_
33	therapeutic	therapeutic	ADJ	JJ	Degree=Pos	35	amod	35:amod	Entity=(abstract-57
34	drug	drug	NOUN	NN	Number=Sing	35	compound	35:compound	Entity=(substance-51)
35	targets	target	NOUN	NNS	Number=Plur	31	nmod	31:nmod:to	_
36	of	of	ADP	IN	_	37	case	37:case	_
37	interest	interest	NOUN	NN	Number=Sing	35	nmod	35:nmod:of	Entity=abstract-56)abstract-57)
38	.	.	PUNCT	.	_	11	punct	11:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-11
# text = Till today , cyclic peptides as therapeutics in regulating glucose metabolism by inhibiting proteases have not been reported for the treatment of diabetes mellitus .
1	Till	till	ADP	IN	_	2	case	2:case	Discourse=sequence:32->27
2	today	today	NOUN	NN	Number=Sing	18	obl	18:obl:till	Entity=(time-58)
3	,	,	PUNCT	,	_	2	punct	2:punct	_
4	cyclic	cyclic	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(substance-30
5	peptides	peptide	NOUN	NNS	Number=Plur	18	nsubj:pass	18:nsubj:pass	_
6	as	as	ADP	IN	_	7	case	7:case	_
7	therapeutics	therapeutics	NOUN	NNS	Number=Plur	5	nmod	5:nmod:as	Entity=(abstract-19
8	in	in	SCONJ	IN	_	9	mark	9:mark	Discourse=elaboration:33->32
9	regulating	regulate	VERB	VBG	VerbForm=Ger	7	acl	7:acl:in	_
10	glucose	glucose	NOUN	NN	Number=Sing	11	compound	11:compound	Entity=(abstract-59(substance-60)
11	metabolism	metabolism	NOUN	NN	Number=Sing	9	obj	9:obj	Entity=substance-30)abstract-19)abstract-59)
12	by	by	SCONJ	IN	_	13	mark	13:mark	Discourse=same_unit:34->33
13	inhibiting	inhibit	VERB	VBG	VerbForm=Ger	9	advcl	9:advcl:by	_
14	proteases	protease	NOUN	NNS	Number=Plur	13	obj	13:obj	Entity=(abstract-15)
15	have	have	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	18	aux	18:aux	_
16	not	not	ADV	RB	Polarity=Neg	18	advmod	18:advmod	_
17	been	be	AUX	VBN	Tense=Past|VerbForm=Part	18	aux:pass	18:aux:pass	_
18	reported	report	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
19	for	for	ADP	IN	_	21	case	21:case	_
20	the	the	DET	DT	Definite=Def|PronType=Art	21	det	21:det	Entity=(abstract-61
21	treatment	treatment	NOUN	NN	Number=Sing	18	obl	18:obl:for	_
22	of	of	ADP	IN	_	23	case	23:case	_
23	diabetes	diabet	NOUN	NNS	Number=Plur	21	nmod	21:nmod:of	Entity=(abstract-8
24	mellitus	mellitus	NOUN	NN	Number=Sing	23	flat	23:flat	Entity=abstract-61)abstract-8)
25	.	.	PUNCT	.	_	18	punct	18:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-12
# text = In Mexico , approximately 11.5 million people live with diabetes mellitus ( DM ) , which is the main leading cause of acquired blindness , non-traumatic lower-limb amputations , and chronic kidney failure diseases .
1	In	in	ADP	IN	_	2	case	2:case	Discourse=sequence:35->27
2	Mexico	Mexico	PROPN	NNP	Number=Sing	8	obl	8:obl:in	Entity=(place-62)
3	,	,	PUNCT	,	_	2	punct	2:punct	_
4	approximately	approximately	ADV	RB	Degree=Pos	6	advmod	6:advmod	Entity=(person-63
5	11.5	11.5	NUM	CD	NumForm=Digit|NumType=Card	6	compound	6:compound	_
6	million	1000000	NUM	CD	NumForm=Digit|NumType=Card	7	nummod	7:nummod	_
7	people	person	NOUN	NNS	Number=Plur	8	nsubj	8:nsubj	Entity=person-63)
8	live	live	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
9	with	with	ADP	IN	_	10	case	10:case	_
10	diabetes	diabet	NOUN	NNS	Number=Plur	8	obl	8:obl:with|21:nsubj	Entity=(abstract-8
11	mellitus	mellitus	NOUN	NN	Number=Sing	10	flat	10:flat	Entity=abstract-8)
12	(	(	PUNCT	-LRB-	_	13	punct	13:punct	Discourse=elaboration:36->35
13	DM	DM	PROPN	NNP	Number=Sing	10	appos	10:appos	Entity=(person-64)
14	)	)	PUNCT	-RRB-	_	13	punct	13:punct	_
15	,	,	PUNCT	,	_	21	punct	21:punct	_
16	which	which	PRON	WDT	PronType=Rel	21	nsubj	10:ref	Discourse=elaboration:37->35|Entity=(abstract-65
17	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	21	cop	21:cop	_
18	the	the	DET	DT	Definite=Def|PronType=Art	21	det	21:det	_
19	main	main	ADJ	JJ	Degree=Pos	21	amod	21:amod	_
20	leading	lead	VERB	VBG	VerbForm=Ger	21	amod	21:amod	_
21	cause	cause	NOUN	NN	Number=Sing	10	acl:relcl	10:acl:relcl	_
22	of	of	ADP	IN	_	24	case	24:case	_
23	acquired	acquire	VERB	VBN	Tense=Past|VerbForm=Part	24	amod	24:amod	Entity=(abstract-66
24	blindness	blindness	NOUN	NN	Number=Sing	21	nmod	21:nmod:of	Entity=abstract-66)
25	,	,	PUNCT	,	_	28	punct	28:punct	_
26	non-traumatic	non-traumatic	ADJ	JJ	Degree=Pos|Polarity=Neg	28	amod	28:amod	Entity=(event-67
27	lower-limb	lower-limb	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=(event-68)
28	amputations	amputation	NOUN	NNS	Number=Plur	24	conj	21:nmod:of|24:conj:and	Entity=event-67)
29	,	,	PUNCT	,	_	34	punct	34:punct	_
30	and	and	CCONJ	CC	_	34	cc	34:cc	_
31	chronic	chronic	ADJ	JJ	Degree=Pos	34	amod	34:amod	Entity=(abstract-5
32	kidney	kidney	NOUN	NN	Number=Sing	33	compound	33:compound	Entity=(event-69(object-70)
33	failure	failure	NOUN	NN	Number=Sing	34	compound	34:compound	Entity=event-69)
34	diseases	disease	NOUN	NNS	Number=Plur	24	conj	21:nmod:of|24:conj:and	Entity=abstract-65)abstract-5)
35	.	.	PUNCT	.	_	8	punct	8:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-13
# text = Human dipeptidyl peptidase-4 ( DPP4 ) is a serine protease , well known FDA-approved therapeutic drug target for regulating blood glucose metabolism and treating diabetes mellitus .
1	Human	Human	ADJ	JJ	Degree=Pos	3	amod	3:amod	Discourse=joint:38->4|Entity=(abstract-71
2	dipeptidyl	dipeptidyl	NOUN	NN	Number=Sing	3	compound	3:compound	Entity=(abstract-72)
3	peptidase-4	peptidase-4	NOUN	NN	Number=Sing	10	nsubj	10:nsubj	Entity=abstract-71)
4	(	(	PUNCT	-LRB-	_	5	punct	5:punct	Discourse=restatement:39->38
5	DPP4	DPP4	PROPN	NNP	Number=Sing	3	appos	3:appos	Entity=(abstract-71)
6	)	)	PUNCT	-RRB-	_	5	punct	5:punct	_
7	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	10	cop	10:cop	Discourse=same_unit:40->38
8	a	a	DET	DT	Definite=Ind|PronType=Art	10	det	10:det	Entity=(abstract-71
9	serine	serine	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(animal-12)
10	protease	protease	NOUN	NN	Number=Sing	0	root	0:root	Entity=abstract-71)
11	,	,	PUNCT	,	_	17	punct	17:punct	_
12	well	well	ADV	RB	Degree=Pos	13	advmod	13:advmod	Entity=(abstract-71
13	known	know	VERB	VBN	Tense=Past|VerbForm=Part	17	amod	17:amod	_
14	FDA-approved	FDA-approved	PROPN	NNP	Number=Sing	17	compound	17:compound	Entity=(organization-73)
15	therapeutic	therapeutic	ADJ	JJ	Degree=Pos	16	amod	16:amod	Entity=(substance-51
16	drug	drug	NOUN	NN	Number=Sing	17	compound	17:compound	Entity=substance-51)
17	target	target	NOUN	NN	Number=Sing	10	appos	10:appos	Entity=abstract-71)
18	for	for	SCONJ	IN	_	19	mark	19:mark	Discourse=purpose:41->38
19	regulating	regulate	VERB	VBG	VerbForm=Ger	10	acl	10:acl:for	_
20	blood	blood	NOUN	NN	Number=Sing	21	compound	21:compound	Entity=(abstract-59(substance-60(substance-74)
21	glucose	glucose	NOUN	NN	Number=Sing	22	compound	22:compound	Entity=substance-60)
22	metabolism	metabolism	NOUN	NN	Number=Sing	19	obj	19:obj	Entity=abstract-59)
23	and	and	CCONJ	CC	_	24	cc	24:cc	Discourse=joint:42->41
24	treating	treat	VERB	VBG	VerbForm=Ger	19	conj	10:acl:for|19:conj:and	_
25	diabetes	diabet	NOUN	NNS	Number=Plur	24	obj	24:obj	Entity=(abstract-8)
26	mellitus	mellitus	NOUN	NN	Number=Sing	24	obj	24:obj	Entity=(abstract-75)
27	.	.	PUNCT	.	_	10	punct	10:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-14
# text = Sitagliptin , Vildagliptin , Anagliptin , Saxagliptin , and Alogliptin are the main clinically used chemicals for human dipeptidyl peptidase-4 ( DPP4 ) inhibition despite their side effects as pancreatitis , nausea , and anemia .
1	Sitagliptin	Sitagliptin	PROPN	NNP	Number=Sing	16	nsubj	16:nsubj	Discourse=joint:43->4|Entity=(abstract-76)
2	,	,	PUNCT	,	_	3	punct	3:punct	_
3	Vildagliptin	Vildagliptin	PROPN	NNP	Number=Sing	1	conj	1:conj:and|16:nsubj	Entity=(substance-77)
4	,	,	PUNCT	,	_	5	punct	5:punct	_
5	Anagliptin	Anagliptin	PROPN	NNP	Number=Sing	1	conj	1:conj:and|16:nsubj	Entity=(plant-78)
6	,	,	PUNCT	,	_	7	punct	7:punct	_
7	Saxagliptin	Saxagliptin	PROPN	NNP	Number=Sing	1	conj	1:conj:and|16:nsubj	Entity=(plant-79)
8	,	,	PUNCT	,	_	10	punct	10:punct	_
9	and	and	CCONJ	CC	_	10	cc	10:cc	_
10	Alogliptin	Alogliptin	PROPN	NNP	Number=Sing	1	conj	1:conj:and|16:nsubj	Entity=(substance-80)
11	are	be	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	16	cop	16:cop	_
12	the	the	DET	DT	Definite=Def|PronType=Art	16	det	16:det	Entity=(substance-80
13	main	main	ADJ	JJ	Degree=Pos	16	amod	16:amod	_
14	clinically	clinically	ADV	RB	Degree=Pos	15	advmod	15:advmod	_
15	used	use	VERB	VBN	Tense=Past|VerbForm=Part	16	amod	16:amod	_
16	chemicals	chemical	NOUN	NNS	Number=Plur	0	root	0:root	_
17	for	for	ADP	IN	_	24	case	24:case	_
18	human	human	ADJ	JJ	Degree=Pos	24	amod	24:amod	Entity=(abstract-81
19	dipeptidyl	dipeptidyl	NOUN	NN	Number=Sing	20	compound	20:compound	Entity=(abstract-71(abstract-72)
20	peptidase-4	peptidase-4	NOUN	NN	Number=Sing	24	compound	24:compound	Entity=abstract-71)
21	(	(	PUNCT	-LRB-	_	22	punct	22:punct	Discourse=restatement:44->43
22	DPP4	DPP4	PROPN	NNP	Number=Sing	20	appos	20:appos	Entity=(abstract-71)
23	)	)	PUNCT	-RRB-	_	22	punct	22:punct	_
24	inhibition	inhibition	NOUN	NN	Number=Sing	16	nmod	16:nmod:for	Discourse=same_unit:45->43|Entity=abstract-81)
25	despite	despite	ADP	IN	_	28	case	28:case	Discourse=concession:46->45
26	their	their	PRON	PRP$	Number=Plur|Person=3|Poss=Yes|PronType=Prs	28	nmod:poss	28:nmod:poss	Entity=(abstract-82(substance-80)
27	side	side	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=(abstract-83)
28	effects	effect	NOUN	NNS	Number=Plur	16	nmod	16:nmod:despite	_
29	as	as	ADP	IN	_	30	case	30:case	_
30	pancreatitis	pancreatitis	NOUN	NN	Number=Sing	28	nmod	28:nmod:as	Entity=(abstract-84)
31	,	,	PUNCT	,	_	32	punct	32:punct	_
32	nausea	nausea	NOUN	NN	Number=Sing	30	conj	28:nmod:as|30:conj:and	Entity=(event-85)
33	,	,	PUNCT	,	_	35	punct	35:punct	_
34	and	and	CCONJ	CC	_	35	cc	35:cc	_
35	anemia	anemia	NOUN	NN	Number=Sing	30	conj	28:nmod:as|30:conj:and	Entity=substance-80)abstract-82)(abstract-35)
36	.	.	PUNCT	.	_	16	punct	16:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-15
# text = It is well known that incretin hormones glucagon-like peptide 1 ( GLP-1 ) and glucose-dependent insulinotropic polypeptide ( GIP ) are responsible for insulin release and glucose regulation .
1	It	it	PRON	PRP	Case=Acc|Gender=Neut|Number=Sing|Person=3|PronType=Prs	4	expl	4:expl	Discourse=attribution:47->48|Entity=(abstract-35)
2	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	4	aux:pass	4:aux:pass	_
3	well	well	ADV	RB	Degree=Pos	4	advmod	4:advmod	_
4	known	know	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
5	that	that	SCONJ	IN	_	22	mark	22:mark	Discourse=joint:48->4
6	incretin	incretin	ADJ	JJ	Degree=Pos	7	amod	7:amod	Entity=(substance-86
7	hormones	hormone	NOUN	NNS	Number=Plur	22	nsubj	22:nsubj	Entity=substance-86)
8	glucagon-like	glucagon-like	ADJ	JJ	Degree=Pos	9	amod	9:amod	Entity=(substance-43
9	peptide	peptide	NOUN	NN	Number=Sing	22	nsubj	22:nsubj	_
10	1	1	NUM	CD	NumForm=Digit|NumType=Card	9	dep	9:dep	Entity=substance-43)
11	(	(	PUNCT	-LRB-	_	12	punct	12:punct	Discourse=restatement:49->48
12	GLP-1	GLP-1	PROPN	NNP	Number=Sing	9	appos	9:appos	Entity=(abstract-87)
13	)	)	PUNCT	-RRB-	_	12	punct	12:punct	_
14	and	and	CCONJ	CC	_	17	cc	17:cc	Discourse=same_unit:50->48
15	glucose-dependent	glucose-dependent	ADJ	JJ	Degree=Pos	17	amod	17:amod	Entity=(place-88
16	insulinotropic	insulinotropic	ADJ	JJ	Degree=Pos	17	amod	17:amod	_
17	polypeptide	polypeptide	NOUN	NN	Number=Sing	9	conj	9:conj:and|22:nsubj	Entity=place-88)
18	(	(	PUNCT	-LRB-	_	19	punct	19:punct	Discourse=restatement:51->50
19	GIP	GIP	PROPN	NNP	Number=Sing	17	appos	17:appos	Entity=(abstract-89)
20	)	)	PUNCT	-RRB-	_	19	punct	19:punct	_
21	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	22	cop	22:cop	Discourse=same_unit:52->48
22	responsible	responsible	ADJ	JJ	Degree=Pos	4	csubj:pass	4:csubj:pass	_
23	for	for	ADP	IN	_	25	case	25:case	_
24	insulin	insulin	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(event-90(substance-91)
25	release	release	NOUN	NN	Number=Sing	22	obl	22:obl:for	Entity=event-90)
26	and	and	CCONJ	CC	_	28	cc	28:cc	_
27	glucose	glucose	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=(abstract-92(substance-60)
28	regulation	regulation	NOUN	NN	Number=Sing	25	conj	22:obl:for|25:conj:and	Entity=abstract-92)
29	.	.	PUNCT	.	_	4	punct	4:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-16
# text = These hormones are inactivated by a serine protease human dipeptidyl peptidase-4 ( DPP4 ) .
1	These	this	DET	DT	Number=Plur|PronType=Dem	2	det	2:det	Discourse=joint:53->4|Entity=(substance-86
2	hormones	hormone	NOUN	NNS	Number=Plur	4	nsubj:pass	4:nsubj:pass	Entity=substance-86)
3	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	4	aux:pass	4:aux:pass	_
4	inactivated	inactivate	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
5	by	by	ADP	IN	_	8	case	8:case	_
6	a	a	DET	DT	Definite=Ind|PronType=Art	8	det	8:det	Entity=(abstract-71
7	serine	serine	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(animal-12)
8	protease	protease	NOUN	NN	Number=Sing	4	obl	4:obl:by	Entity=abstract-71)
9	human	human	ADJ	JJ	Degree=Pos	11	amod	11:amod	Entity=(abstract-71
10	dipeptidyl	dipeptidyl	NOUN	NN	Number=Sing	11	compound	11:compound	Entity=(abstract-72)
11	peptidase-4	peptidase-4	NOUN	NN	Number=Sing	8	appos	8:appos	Entity=abstract-71)
12	(	(	PUNCT	-LRB-	_	13	punct	13:punct	Discourse=restatement:54->53
13	DPP4	DPP4	X	FW	_	11	appos	11:appos	_
14	)	)	PUNCT	-RRB-	_	13	punct	13:punct	_
15	.	.	PUNCT	.	_	4	punct	4:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-17
# text = Since natural cyclic peptides are proven to inhibit various proteases , and to consider the beneficial aspects of cyclic peptides in comparison to small chemicals , like less toxicity , no accumulation in organs , and rapid degradation of peptides , we hypothesized that cyclic peptides from natural sources could be an alternative source of therapeutics to inhibit serine protease DPP4 for treatment of diabetes mellitus .
1	Since	since	SCONJ	IN	_	6	mark	6:mark	Discourse=joint:55->4
2	natural	natural	ADJ	JJ	Degree=Pos	4	amod	4:amod	Entity=(substance-30
3	cyclic	cyclic	ADJ	JJ	Degree=Pos	4	amod	4:amod	_
4	peptides	peptide	NOUN	NNS	Number=Plur	6	nsubj:pass	6:nsubj:pass|8:nsubj:xsubj	Entity=substance-30)
5	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	6	aux:pass	6:aux:pass|14:aux:pass	_
6	proven	prove	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	43	advcl	43:advcl:since	_
7	to	to	PART	TO	_	8	mark	8:mark	_
8	inhibit	inhibit	VERB	VB	VerbForm=Inf	6	xcomp	6:xcomp	_
9	various	various	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(abstract-15
10	proteases	protease	NOUN	NNS	Number=Plur	8	obj	8:obj	Entity=abstract-15)
11	,	,	PUNCT	,	_	14	punct	14:punct	_
12	and	and	CCONJ	CC	_	14	cc	14:cc	Discourse=preparation:56->58
13	to	to	PART	TO	_	14	mark	14:mark	_
14	consider	consider	VERB	VB	Mood=Imp|Person=2|VerbForm=Fin	6	conj	6:conj:and|43:advcl:since	_
15	the	the	DET	DT	Definite=Def|PronType=Art	17	det	17:det	Entity=(abstract-93
16	beneficial	beneficial	ADJ	JJ	Degree=Pos	17	amod	17:amod	_
17	aspects	aspect	NOUN	NNS	Number=Plur	14	obj	14:obj	_
18	of	of	ADP	IN	_	20	case	20:case	_
19	cyclic	cyclic	ADJ	JJ	Degree=Pos	20	amod	20:amod	Entity=(substance-30
20	peptides	peptide	NOUN	NNS	Number=Plur	17	nmod	17:nmod:of	Entity=substance-30)
21	in	in	ADP	IN	_	22	case	22:case	_
22	comparison	comparison	NOUN	NN	Number=Sing	14	obl	14:obl:in	_
23	to	to	ADP	IN	_	25	case	25:case	_
24	small	small	ADJ	JJ	Degree=Pos	25	amod	25:amod	Entity=(substance-80
25	chemicals	chemical	NOUN	NNS	Number=Plur	22	nmod	22:nmod:to	Entity=substance-80)
26	,	,	PUNCT	,	_	29	punct	29:punct	_
27	like	like	ADP	IN	_	29	case	29:case	_
28	less	less	ADJ	JJR	Degree=Cmp	29	amod	29:amod	Entity=(abstract-28
29	toxicity	toxicity	NOUN	NN	Number=Sing	17	nmod	17:nmod:like	Entity=abstract-28)
30	,	,	PUNCT	,	_	32	punct	32:punct	_
31	no	no	DET	DT	Polarity=Neg	32	det	32:det	Entity=(abstract-94
32	accumulation	accumulation	NOUN	NN	Number=Sing	29	conj	17:nmod:like|29:conj:and	_
33	in	in	ADP	IN	_	34	case	34:case	_
34	organs	organ	NOUN	NNS	Number=Plur	32	nmod	32:nmod:in	Entity=abstract-94)(object-95)
35	,	,	PUNCT	,	_	38	punct	38:punct	_
36	and	and	CCONJ	CC	_	38	cc	38:cc	_
37	rapid	rapid	ADJ	JJ	Degree=Pos	38	amod	38:amod	Entity=(event-96
38	degradation	degradation	NOUN	NN	Number=Sing	29	conj	17:nmod:like|29:conj:and	_
39	of	of	ADP	IN	_	40	case	40:case	_
40	peptides	peptide	NOUN	NNS	Number=Plur	38	nmod	38:nmod:of	Entity=abstract-93)event-96)(substance-30)
41	,	,	PUNCT	,	_	6	punct	6:punct	_
42	we	we	PRON	PRP	Case=Nom|Number=Plur|Person=1|PronType=Prs	43	nsubj	43:nsubj	Discourse=attribution:57->58|Entity=(person-97)
43	hypothesized	hypothesize	VERB	VBD	Mood=Ind|Number=Plur|Person=1|Tense=Past|VerbForm=Fin	0	root	0:root	_
44	that	that	SCONJ	IN	_	54	mark	54:mark	Discourse=joint:58->4
45	cyclic	cyclic	ADJ	JJ	Degree=Pos	46	amod	46:amod	Entity=(substance-30
46	peptides	peptide	NOUN	NNS	Number=Plur	54	nsubj	54:nsubj	_
47	from	from	ADP	IN	_	49	case	49:case	_
48	natural	natural	ADJ	JJ	Degree=Pos	49	amod	49:amod	Entity=(abstract-98
49	sources	source	NOUN	NNS	Number=Plur	46	nmod	46:nmod:from	Entity=substance-30)abstract-98)
50	could	could	AUX	MD	VerbForm=Fin	54	aux	54:aux	_
51	be	be	AUX	VB	VerbForm=Inf	54	cop	54:cop	_
52	an	a	DET	DT	Definite=Ind|PronType=Art	54	det	54:det	Entity=(substance-30
53	alternative	alternative	ADJ	JJ	Degree=Pos	54	amod	54:amod	_
54	source	source	NOUN	NN	Number=Sing	43	ccomp	43:ccomp	_
55	of	of	ADP	IN	_	56	case	56:case	_
56	therapeutics	therapeutics	NOUN	NNS	Number=Plur	54	nmod	54:nmod:of	Entity=(abstract-19)
57	to	to	PART	TO	_	58	mark	58:mark	Discourse=purpose:59->58
58	inhibit	inhibit	VERB	VB	VerbForm=Inf	54	acl	54:acl:to	_
59	serine	serine	NOUN	NN	Number=Sing	60	compound	60:compound	Entity=(abstract-71(animal-12)
60	protease	protease	NOUN	NN	Number=Sing	58	obj	58:obj	Entity=abstract-71)
61	DPP4	DPP4	PROPN	NNP	Number=Sing	58	obj	58:obj	Entity=(abstract-71)
62	for	for	ADP	IN	_	63	case	63:case	_
63	treatment	treatment	NOUN	NN	Number=Sing	58	obl	58:obl:for	Entity=(event-99
64	of	of	ADP	IN	_	66	case	66:case	_
65	diabetes	diabet	NOUN	NNS	Number=Plur	66	compound	66:compound	Entity=(abstract-75(abstract-8)
66	mellitus	mellitus	NOUN	NN	Number=Sing	63	nmod	63:nmod:of	Entity=substance-30)event-99)abstract-75)
67	.	.	PUNCT	.	_	43	punct	43:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-18
# text = Among various naturally occurring cyclic peptides , oxytocin ( natural cyclic peptide ) was chosen in this study to prove our hypothesis that , cyclic peptides possess serine protease inhibition activity , and specifically inhibit DPP4 .
1	Among	among	ADP	IN	_	6	case	6:case	Discourse=joint:60->58
2	various	various	DET	JJ	Degree=Pos	6	det	6:det	Entity=(substance-30
3	naturally	naturally	ADV	RB	Degree=Pos	4	advmod	4:advmod	_
4	occurring	occur	VERB	VBG	VerbForm=Ger	6	amod	6:amod	_
5	cyclic	cyclic	ADJ	JJ	Degree=Pos	6	amod	6:amod	_
6	peptides	peptide	NOUN	NNS	Number=Plur	15	obl	15:obl:among	Entity=substance-30)
7	,	,	PUNCT	,	_	6	punct	6:punct	_
8	oxytocin	oxytocin	NOUN	NN	Number=Sing	15	nsubj:pass	15:nsubj:pass|20:nsubj:xsubj	Discourse=joint:61->58|Entity=(substance-100)
9	(	(	PUNCT	-LRB-	_	12	punct	12:punct	Discourse=elaboration:62->61
10	natural	natural	ADJ	JJ	Degree=Pos	12	amod	12:amod	Entity=(substance-43
11	cyclic	cyclic	NOUN	NN	Number=Sing	12	compound	12:compound	Entity=(person-101)
12	peptide	peptide	NOUN	NN	Number=Sing	8	appos	8:appos	Entity=substance-43)
13	)	)	PUNCT	-RRB-	_	12	punct	12:punct	_
14	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	15	aux:pass	15:aux:pass	Discourse=same_unit:63->61
15	chosen	choose	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
16	in	in	ADP	IN	_	18	case	18:case	_
17	this	this	DET	DT	Number=Sing|PronType=Dem	18	det	18:det	Entity=(abstract-102
18	study	study	NOUN	NN	Number=Sing	15	obl	15:obl:in	Entity=abstract-102)
19	to	to	PART	TO	_	20	mark	20:mark	Discourse=purpose:64->61
20	prove	prove	VERB	VB	VerbForm=Inf	15	xcomp	15:xcomp	_
21	our	our	PRON	PRP$	Number=Plur|Person=1|Poss=Yes|PronType=Prs	22	nmod:poss	22:nmod:poss	Entity=(abstract-103(person-97)
22	hypothesis	hypothesis	NOUN	NN	Number=Sing	20	obj	20:obj	_
23	that	that	SCONJ	IN	_	27	mark	27:mark	Discourse=joint:65->64
24	,	,	PUNCT	,	_	23	punct	23:punct	_
25	cyclic	cyclic	ADJ	JJ	Degree=Pos	26	amod	26:amod	Entity=(substance-30
26	peptides	peptide	NOUN	NNS	Number=Plur	27	nsubj	27:nsubj|35:nsubj	Entity=substance-30)
27	possess	possess	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	22	acl	22:acl:that	_
28	serine	serine	NOUN	NN	Number=Sing	31	compound	31:compound	Entity=(abstract-104(animal-12)
29	protease	protease	NOUN	NN	Number=Sing	31	compound	31:compound	Entity=(abstract-71)
30	inhibition	inhibition	NOUN	NN	Number=Sing	31	compound	31:compound	Entity=(abstract-81)
31	activity	activity	NOUN	NN	Number=Sing	27	obj	27:obj	Entity=abstract-104)
32	,	,	PUNCT	,	_	35	punct	35:punct	_
33	and	and	CCONJ	CC	_	35	cc	35:cc	Discourse=joint:66->65
34	specifically	specifically	ADV	RB	Degree=Pos	35	advmod	35:advmod	_
35	inhibit	inhibit	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	27	conj	22:acl:that|27:conj:and	_
36	DPP4	DPP4	PROPN	NNP	Number=Sing	35	obj	35:obj	Entity=abstract-103)(abstract-71)
37	.	.	PUNCT	.	_	15	punct	15:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-19
# text = To demonstrate our hypothesis , activity atlas and field-based models of DPP4 inhibitors from natural origin were utilized to elucidate molecular insights of oxytocin peptide into DPP4 inhibition .
1	To	to	PART	TO	_	2	mark	2:mark	Discourse=purpose:67->66
2	demonstrate	demonstrate	VERB	VB	VerbForm=Inf	18	advcl	18:advcl:to	_
3	our	our	PRON	PRP$	Number=Plur|Person=1|Poss=Yes|PronType=Prs	4	nmod:poss	4:nmod:poss	Entity=(abstract-103(person-97)
4	hypothesis	hypothesis	NOUN	NN	Number=Sing	2	obj	2:obj	Entity=abstract-103)
5	,	,	PUNCT	,	_	2	punct	2:punct	_
6	activity	activity	NOUN	NN	Number=Sing	7	compound	7:compound	Discourse=joint:68->67|Entity=(abstract-105(abstract-104)
7	atlas	atla	NOUN	NN	Number=Sing	18	nsubj:pass	18:nsubj:pass|20:nsubj:xsubj	Entity=abstract-105)
8	and	and	CCONJ	CC	_	10	cc	10:cc	_
9	field-based	field-based	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(abstract-106
10	models	model	NOUN	NNS	Number=Plur	7	conj	7:conj:and|18:nsubj:xsubj|20:nsubj:xsubj	_
11	of	of	ADP	IN	_	13	case	13:case	_
12	DPP4	DPP4	PROPN	NNP	Number=Sing	13	compound	13:compound	Entity=(abstract-16(abstract-71)
13	inhibitors	inhibitor	NOUN	NNS	Number=Plur	10	nmod	10:nmod:of	_
14	from	from	ADP	IN	_	16	case	16:case	_
15	natural	natural	ADJ	JJ	Degree=Pos	16	amod	16:amod	Entity=(abstract-107
16	origin	origin	NOUN	NN	Number=Sing	13	nmod	13:nmod:from	Entity=abstract-106)abstract-16)abstract-107)
17	were	be	AUX	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	18	aux:pass	18:aux:pass	_
18	utilized	utilize	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
19	to	to	PART	TO	_	20	mark	20:mark	Discourse=purpose:69->68
20	elucidate	elucidate	VERB	VB	VerbForm=Inf	18	xcomp	18:xcomp	_
21	molecular	molecular	ADJ	JJ	Degree=Pos	22	amod	22:amod	Entity=(abstract-108
22	insights	insight	NOUN	NNS	Number=Plur	20	obj	20:obj	_
23	of	of	ADP	IN	_	25	case	25:case	_
24	oxytocin	oxytocin	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(substance-43(substance-100)
25	peptide	peptide	NOUN	NN	Number=Sing	22	nmod	22:nmod:of	Entity=abstract-108)substance-43)
26	into	into	ADP	IN	_	28	case	28:case	_
27	DPP4	DPP4	PROPN	NNP	Number=Sing	28	compound	28:compound	Entity=(abstract-81(abstract-71)
28	inhibition	inhibition	NOUN	NN	Number=Sing	20	obl	20:obl:into	Entity=abstract-81)
29	.	.	PUNCT	.	_	18	punct	18:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-20
# text = In addition , molecular docking simulations were used to understand the binding poses and interacting residues responsible for inhibitory activity .
1	In	in	ADP	IN	_	2	case	2:case	Discourse=joint:70->68
2	addition	addition	NOUN	NN	Number=Sing	8	obl	8:obl:in	_
3	,	,	PUNCT	,	_	2	punct	2:punct	_
4	molecular	molecular	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(abstract-52(event-53
5	docking	docking	NOUN	NN	Number=Sing	6	compound	6:compound	Entity=event-53)
6	simulations	simulation	NOUN	NNS	Number=Plur	8	nsubj:pass	8:nsubj:pass|10:nsubj:xsubj	Entity=abstract-52)
7	were	be	AUX	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	8	aux:pass	8:aux:pass	_
8	used	use	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
9	to	to	PART	TO	_	10	mark	10:mark	Discourse=purpose:71->70
10	understand	understand	VERB	VB	VerbForm=Inf	8	xcomp	8:xcomp	_
11	the	the	DET	DT	Definite=Def|PronType=Art	13	det	13:det	Entity=(abstract-109
12	binding	binding	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(object-27)
13	poses	pose	NOUN	NNS	Number=Plur	10	obj	10:obj	Entity=abstract-109)
14	and	and	CCONJ	CC	_	16	cc	16:cc	_
15	interacting	interact	VERB	VBG	VerbForm=Ger	16	amod	16:amod	Entity=(substance-110
16	residues	residue	NOUN	NNS	Number=Plur	13	conj	10:obj|13:conj:and	_
17	responsible	responsible	ADJ	JJ	Degree=Pos	13	acl	13:acl	Discourse=elaboration:72->71
18	for	for	ADP	IN	_	20	case	20:case	_
19	inhibitory	inhibitory	ADJ	JJ	Degree=Pos	20	amod	20:amod	Entity=(abstract-104
20	activity	activity	NOUN	NN	Number=Sing	17	obl	17:obl:for	Entity=substance-110)abstract-104)
21	.	.	PUNCT	.	_	8	punct	8:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-21
# text = Also , the stability of water molecules at the binding site of oxytocin was studied using 3D reference interaction site model ( 3D-RISM ) to gain deep insights into the binding of the cyclic peptide at DPP4 druggable region .
1	Also	also	ADV	RB	_	15	advmod	15:advmod	Discourse=joint:73->70
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	the	the	DET	DT	Definite=Def|PronType=Art	4	det	4:det	Entity=(abstract-111
4	stability	stability	NOUN	NN	Number=Sing	15	nsubj:pass	15:nsubj:pass|16:nsubj:xsubj	_
5	of	of	ADP	IN	_	7	case	7:case	_
6	water	water	NOUN	NN	Number=Sing	7	compound	7:compound	Entity=(object-112(substance-113)
7	molecules	molecule	NOUN	NNS	Number=Plur	4	nmod	4:nmod:of	Entity=object-112)
8	at	at	ADP	IN	_	11	case	11:case	_
9	the	the	DET	DT	Definite=Def|PronType=Art	11	det	11:det	Entity=(place-114
10	binding	binding	NOUN	NN	Number=Sing	11	compound	11:compound	Entity=(object-27)
11	site	site	NOUN	NN	Number=Sing	4	nmod	4:nmod:at	_
12	of	of	ADP	IN	_	13	case	13:case	_
13	oxytocin	oxytocin	NOUN	NN	Number=Sing	11	nmod	11:nmod:of	Entity=abstract-111)place-114)(substance-100)
14	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	15	aux:pass	15:aux:pass	_
15	studied	study	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
16	using	use	VERB	VBG	VerbForm=Ger	15	xcomp	15:xcomp	Discourse=means:74->73
17	3D	3D	NOUN	NN	Number=Sing	18	compound	18:compound	Entity=(abstract-115
18	reference	reference	NOUN	NN	Number=Sing	21	compound	21:compound	_
19	interaction	interaction	NOUN	NN	Number=Sing	20	compound	20:compound	Entity=(place-114(abstract-116)
20	site	site	NOUN	NN	Number=Sing	21	compound	21:compound	Entity=place-114)
21	model	model	NOUN	NN	Number=Sing	16	obj	16:obj	Entity=abstract-115)
22	(	(	PUNCT	-LRB-	_	23	punct	23:punct	Discourse=restatement:75->74
23	3D-RISM	3D-RISM	PROPN	NNP	Number=Sing	21	appos	21:appos	Entity=(abstract-115)
24	)	)	PUNCT	-RRB-	_	23	punct	23:punct	_
25	to	to	PART	TO	_	26	mark	26:mark	Discourse=purpose:76->74
26	gain	gain	VERB	VB	VerbForm=Inf	16	advcl	16:advcl:to	_
27	deep	deep	ADJ	JJ	Degree=Pos	28	amod	28:amod	Entity=(abstract-108
28	insights	insight	NOUN	NNS	Number=Plur	26	obj	26:obj	_
29	into	into	ADP	IN	_	31	case	31:case	_
30	the	the	DET	DT	Definite=Def|PronType=Art	31	det	31:det	Entity=(object-27
31	binding	binding	NOUN	NN	Number=Sing	28	nmod	28:nmod:into	_
32	of	of	ADP	IN	_	35	case	35:case	_
33	the	the	DET	DT	Definite=Def|PronType=Art	35	det	35:det	Entity=(substance-43
34	cyclic	cyclic	ADJ	JJ	Degree=Pos	35	amod	35:amod	_
35	peptide	peptide	NOUN	NN	Number=Sing	31	nmod	31:nmod:of	_
36	at	at	ADP	IN	_	39	case	39:case	_
37	DPP4	DPP4	PROPN	NNP	Number=Sing	39	compound	39:compound	Entity=(place-117(abstract-71)
38	druggable	druggable	ADJ	JJ	Degree=Pos	39	amod	39:amod	_
39	region	region	NOUN	NN	Number=Sing	35	nmod	35:nmod:at	Entity=abstract-108)object-27)substance-43)place-117)
40	.	.	PUNCT	.	_	15	punct	15:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_cyclic-22
# text = Finally , fluorescence assay was used to demonstrate the potential role of oxytocin as a DPP4 inhibitor experimentally .
1	Finally	finally	ADV	RB	Degree=Pos	6	advmod	6:advmod	Discourse=sequence:77->73
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	fluorescence	fluorescence	NOUN	NN	Number=Sing	4	compound	4:compound	Entity=(abstract-118(abstract-119)
4	assay	assay	NOUN	NN	Number=Sing	6	nsubj:pass	6:nsubj:pass|8:nsubj:xsubj	Entity=abstract-118)
5	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	6	aux:pass	6:aux:pass	_
6	used	use	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
7	to	to	PART	TO	_	8	mark	8:mark	Discourse=purpose:78->77
8	demonstrate	demonstrate	VERB	VB	VerbForm=Inf	6	xcomp	6:xcomp	_
9	the	the	DET	DT	Definite=Def|PronType=Art	11	det	11:det	Entity=(abstract-120
10	potential	potential	ADJ	JJ	Degree=Pos	11	amod	11:amod	_
11	role	role	NOUN	NN	Number=Sing	8	obj	8:obj	_
12	of	of	ADP	IN	_	13	case	13:case	_
13	oxytocin	oxytocin	NOUN	NN	Number=Sing	11	nmod	11:nmod:of	Entity=(substance-100
14	as	as	ADP	IN	_	17	case	17:case	_
15	a	a	DET	DT	Definite=Ind|PronType=Art	17	det	17:det	Entity=(abstract-121
16	DPP4	DPP4	PROPN	NNP	Number=Sing	17	compound	17:compound	Entity=(abstract-71)
17	inhibitor	inhibitor	NOUN	NN	Number=Sing	13	nmod	13:nmod:as	Entity=abstract-120)substance-100)abstract-121)
18	experimentally	experimentally	ADV	RB	Degree=Pos	6	advmod	6:advmod	_
19	.	.	PUNCT	.	_	6	punct	6:punct	_

